The Federal Trade Commission on Monday sued AbbVie Inc and other drug companies over allegations they unlawfully sought to delay generic competition for AbbVies blockbuster testosteronereplacement drug AndroGel The commissions lawsuit was the first of its kind since a Supreme Court ruling last year boosted FTC efforts to challenge certain agreements between drug makers that can postpone the introduction of generic drugs The
  